TMO Thermo Fisher Scientific Inc.
TMO Thermo Fisher Scientific Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 2 scans as of 2026-10-16 2 bull converging
POC $576.17 · VWAP $554.16 · +21.6% vs 12m avg buyer
Insiders selling 0 buy / 2 sell · Form 4, 90d $27.9M sold last open-market sell CASPER MARC N
Cluster CEO, EVP + 2 others sold $46.1M, Aug 7–20
Coverage
TMO Price Structure
Loading timeframes…
Peers
Every watchlist TMO belongs to, members best 30-day change first — TMO highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@thebuildout-metrology-inspection
@trace-glp1-manufacturing
@biotech
@healthcare-scan
@healthcare
@biotech-capital-cycle
@biotech-scan
@bargain-bin
@insider-universe
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported EPS $6.68 versus analyst consensus of $6.40 (+4.3%).
full note →Against street estimates
How TMO's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about TMO from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- Thermo Fisher Scientific (TMO) Stock Price & Overview
- Thermo Fisher Scientific Inc. (TMO) Stock Historical Prices & Data - Yahoo Finance
- Thermo Fisher Scientific Q3 Earnings Call Highlights
- Thermo Fisher Scientific Inc. Q3 2026 Earnings Call Summary
- Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Reports Third Quarter 2026 Results
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
TMO research tape
211 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to TMO.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries